-

Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

Healthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer.

Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and interoperability elevated to enterprise grade - capabilities trusted by providers, payers, biopharma, and life sciences clients.

“Tehsin and I share the ambition to leverage technology and data to systemically improve U.S. healthcare,” said Donald Trigg, Chief Executive Officer of Veradigm. “Our clients and teammates will be first-day beneficiaries of the intelligence, expertise, and collaborative purpose he will bring to this role.”

Previously, Syed spent more than two decades at Cerner Corporation, a $5 billion healthcare IT and services leader, where he served as Vice President of Strategic Growth Engineering. During his time there, he led product and platform engineering as well as product operations and was instrumental in developing HealtheIntent—a cloud-based population health platform that enables healthcare organizations to integrate and analyze data to improve quality, cost, and patient outcomes.

“With strategic assets across providers, payers, and life sciences, Veradigm has a strong foundation to turn applied AI into real, daily workflow wins,” said Syed. “I'm excited to lead the development of innovative solutions and services that eliminate friction between providers and payers, reduce costs, and improve health outcomes for the patients they serve.”

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Contacts

Veradigm Contacts:

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Rick Dipper
919-961-6001
rick.dipper@veradigm.com

Veradigm

Pink Limited:MDRX

Release Versions

Contacts

Veradigm Contacts:

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Rick Dipper
919-961-6001
rick.dipper@veradigm.com

More News From Veradigm

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom